Marc Dechamps active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director/Board Member | 2024-06-18 | - |
| Independent Dir/Board Member | 2024-06-18 | - |
Career history of Marc Dechamps
Former positions of Marc Dechamps
| Companies | Position | Start | End |
|---|---|---|---|
Delphi Genetics SA
 Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Chief Executive Officer | - | 2017-06-30 |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Statistics
International
| Belgium | 3 |
| France | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 2 |
|---|---|
Delphi Genetics SA
Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
- Stock Market
- Insiders
- Marc Dechamps
- Experience
